Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Harmony biosciences holdings inc - What They Never Told You

3 Emerging Biotech Firms Pioneering Next-Gen Therapies

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries. Thus, investing in fundamentally stable biotech stocks, Veracyte (VCYT), Amicus Therapeutics (FOLD), and Harmony Biosciences (HRMY), could be one way to capitalize on the industry's prospects. Read more….

StockNews.com

Is Harmony Biosciences Holdings Inc. (HRMY) a Biotech Stock to Consider?

Harmony Biosciences’ (HRMY) recently released growth plans and pipeline advancements have showcased the company’s dedication towards being a top contender in the highly contested biotech market. So, should investors looking to capitalize on the industry’s prospects consider investing in HRMY? Read more….

StockNews.com

3 Under-the-Radar Biotech Stocks Revolutionizing Healthcare

Hidden gems in the biotech sector are reshaping healthcare with breakthroughs in personalized medicine and rare disease treatments. Given the sector’s growing potential, I have highlighted three biotech stocks, Immunocore Holdings (IMCR), BioCryst Pharmaceuticals (BCRX), and Harmony Biosciences Holdings (HRMY) that you might consider adding to your portfolio. Read more….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Emerging Biotech Stocks Developing Breakthrough Therapies

The biotechnology industry is witnessing groundbreaking advancements in genomics, personalized medicine, and gene editing, propelling the sector toward a future of more precise and effective therapies. As a result, fundamentally robust biotech stocks Harmony Biosciences Holdings (HRMY), Treda Pharmaceuticals (TRDA), and Puma Biotechnology (PBYI) could be wise picks. Read further.

StockNews.com

3 Value Biotech Stocks With Breakout Potential in 2024

Given growing healthcare spending, supportive government policies, and technological innovation, the biotechnology industry is poised for solid long-term growth. Thus, investors could consider buying quality biotech stocks Harmony Biosciences (HRMY), Esperion Therapeutics (ESPR), and Entrada Therapeutics (TRDA), which are trading at a discount. Read on….

StockNews.com

3 Biotech Stocks to Monitor for May Moves

The biotech industry is well poised to flourish, buoyed by its strong emphasis on technology-driven advancements to address complex medical challenges and government funding. Hence, quality biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Compugen (CGEN) could be ideal watchlist additions for May. Read more….

StockNews.com

3 Biotech Stocks to Buy in 2024

The biotech industry is expected to grow rapidly due to rising demand for tailored treatments, increased R&D spending, and technological advancements. Therefore, fundamentally strong biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Halozyme Therapeutics (HALO) could be worth adding to your portfolio. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 B-Rated Biotech Stocks to Boost Your Bottom Line

The biotech industry’s growth prospects look promising due to innovative drugs and therapies, government initiatives, and technological advancements. Therefore, investors could consider buying fundamentally strong biotech stocks BioMarin Pharmaceutical (BMRN), Illumina (ILMN), and Harmony Biosciences (HRMY). These stocks are B-rated (Buy) in our proprietary rating system. Read on.

StockNews.com

Are These 3 Biotech Stocks Worth Buying?

The biotech industry’s expansion stems from advancements in cutting-edge medical technologies and the growing demand for food biotechnology. Against this backdrop, should you buy Harmony Biosciences Holdings (HRMY), Exelixis (EXEL), and Surrozen (SRZN)? Let’s find out.

StockNews.com

3 Biotech Gems to Keep on Your Radar

The biotech industry's expansion seems to stem from advancements in drug development, cutting-edge technology, and substantial government backing. Given these factors, prominent biotech stocks Surrozen (SRZN), Harmony Biosciences (HRMY), and Cidara Therapeutics (CDTX) could be solid watchlist additions now. Read on….

StockNews.com

Top 3 Biotech Stocks with Breakout Potential

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics (FOLD), Corcept Therapeutics (CORT), and Harmony Biosciences (HRMY) might be solid buys in 2023. Read on.

StockNews.com

People

Kritika SarmahHer

727 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

BioMarin Pharmaceutical Inc

Entrada Therapeutics Inc

17 stories

CDTX

15 stories

Corcept Therapeutics Incorporated

13 stories

BCRX

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.